Biometrics jobs in the UK and Europe

Mylene Paumier at CK Clinical is currently recruiting for a number of biometric based positions in Europe and the UK:

Please click on the links below to find out more and apply:

 

Compliance Lead – Switzerland

Mylene Paumier is recruiting for a Compliance Lead to join a global pharmaceutical company at their site based in Switzerland on a 6 month contract basis

 

Clinical Operations Manager – Switzerland

Mylene Paumier is recruiting for a Clinical Operations Manager to join a global pharmaceutical company at their site based in Switzerland on a 6 month contract basis

 

Medical Information Associate

Mylene Paumier is recruiting for a Medical Information Associate to join a global pharmaceutical company at their site based in Surrey on a 12 months contract basis

 

Senior Biometrician – Switzerland

Mylene Paumier is recruiting for a Senior Biometrician to join a global pharmaceutical company at their site based in Switzerland on a permanent basis.

 

Are you looking for a new role in the pharmaceutical industry?

Click here to see our latest pharmaceutical roles

 

Metformin

Posted in Featured Jobs, Industry News, NewsTagged in , , , , , , , ,

Roche study shows cancer drug Avastin slows growth

As reported by Reuters, Swiss drug maker Roche have said a new study of cancer drug Avastin showed it significantly extended progression-free survival of people with an aggressive form of brain cancer.

The Phase III AVAglio study met one of its main targets of improving progression-free survival in people with glioblastoma (a very aggressive cancer)

This study showed that people with glioblastoma, a particularly devastating and aggressive cancer without many treatment options, lived significantly longer without their disease worsening when Avastin was added to radiation and temozolomide chemotherapy,” Roche said.

The study’s other main endpoint is the expected time of overall survival, the results of this expected in 2013

 

Are you looking for a new pharmaceutical job in Switzerland or Europe?

Click here to see our latest jobs on Switzerland

Click here to see our latest jobs on Europe

Aleve

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , ,

Icon plans to open a Translational Medicine Research Centre in Manchester

Pharmatimes has reported that Icon has announced plans to further expand its UK hospital-based presence on the Manchester Royal Infirmary Campus by opening a Translational Medicine Research Centre.

ICON has secured a 40,000 square foot pre-let at Citylabs, a newly developed biomedical centre of excellence which was formerly the Manchester Royal Eye Hospital. This new centre will also host biohealth organisations including the Central Manchester University Hospitals NHS Foundation Trust, The University of Manchester, and other commercial research enterprises.

ICON currently operates a hospital-based Clinical Pharmacology Unit on the Manchester Royal Infirmary Campus, where it will continue to run it’s Phase I operations until fully transitioning to the new, larger Citylabs facility, which is scheduled to open in the fourth quarter of 2013.

“We are pleased to be expanding our early phase development services through the establishment of a Centre of Excellence for Translational Medicine in Citylabs,” commented Dr. Mario Rocci, President, ICON Development Solutions. “This expansion will enable ICON to increase the capacity of its Clinical Pharmacology Unit in Manchester as well as the scientific services that are essential in providing a world class offering.”

 

Are you looking for a new job in the clinical industry?

 Click here to see our latest clinical jobs

          

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , ,

AstraZeneca & Assay Depot launch virtual laboratory

Pharmatimes have reported that Astra Zeneca and Assay Depot have launched a new virtual laboratory which will allow the scientist to work from a laptop.

Assay Depot can be compared to Amazon.com but for industry and academic drug researchers looking to tap into research services from drug discovery through to clinical trials.

It offers a single, secure, cloud-based location where researchers can compare service descriptions, view customer reviews, request quotes, place orders, track service progress and retrieve data reports.

The private virtual research laboratory developed by Assay Depot in partnership with AstraZeneca is effectively a vendor relationship-management system with easy access to a network of “thousands” of research-service providers both inside and outside the company.

Mike Snowden, the Astra Zeneca’s vice president of discovery sciences said “We look forward to assessing how the virtual laboratory platform impacts and accelerates productivity in the R&D pipeline,”

 

Are you looking for a new role in the pharmaceutical industry?

Click here to see our latest pharmaceutical roles

Posted in Industry News, NewsTagged in , , , , , , , , , , , , ,

Our Latest Pharmaceutical Jobs – 06.08.2012

Looking for a job in the Pharmaceutical Industry? Please click on the links below to find out about our latest pharmaceutical jobs new in this week:

Clinical:

Senior CRA, Home Based, UK

Clinical Administration Assistant

Associate Clinical Project Manager, Munich

Safety Advisor

Interim Clinical Funding Manager, London

Clinical Team Manager, London

Biometrics:

Operations Manager for Medical Affairs

Medical Information Associate

Clinical Data Manager – The Netherlands

Medical Information Executive – Surrey

Disease Manager – Japan

Lactation Consultant – Japan

Global Data Manager  -Belgium

Medics:

Medical Advisor (Dermatology/Psriosis) South East

Regulatory affairs:

Senior Regulatory Executive (CMC) – Hertfordshire

Regulatory Executive CMC

 

Register your CV with CK Clinical

Not quite what you’re looking for? Click here to register your CV with CK Clinical today.

Once registered, one of our specialist Pharmaceutical Recruitment Consultants will be in contact to discuss your requirements and any relevant pharmaceutical jobs we are recruiting for at the moment. Good luck with your job hunt

 

 

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , , , ,

Olympic anti doping lab to become research facility

The Telegraph has reported that the Olympics anti-doping laboratory  is to be developed after the Games into what officials say will be a world-class research facility that could help revolutionise healthcare.

The lab was provided and equipped by GlaxoSmithKline to carry out more than 6,000 drug tests during the London Olympic and Paralympic Games.

After the games, the London 2012 drug testing laboratories in Harlow, Essex, will become the world’s first “Phenome Centre”, where experts will explore how different people respond to particular diseases and treatments, David Cameron will say.

The £10 million project is aimed at discovering the biological reasons why some people are more vulnerable to particular diseases than others, and why some drugs are only effective in certain patients.  It is hoped that it will help find treatments for conditions like dementia and obesity.

 

Click here to see our latest clinical jobs

Follow us on Twitter @CKClinical to receive more industry news and CK jobs of the week updates

 

 

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , ,

Eli Lilly assists research into Hypoglycemia aware dogs

As reported by Pharmiweb, researchers from Eli Lilly in June began research to better understand why dogs are able to sense severe blood sugar events in their owners and to identify the compound or compounds they smell as part of those events.

For years, people with vision and hearing impairments have benefited from the help and companionship of trained assistance dogs. Only recently, however, have hypoglycemia alert dogs been available to help people with diabetes, typically those with type 1, which is usually diagnosed in children or young adults. These dogs are trained to identify low levels of blood sugar and alert their owners by nudging or making contact with them in some specific way

As a result of a Lilly supported Innovation Day for Global Statistical Sciences, ICAN and Lilly employees launched another study to examine the reproducibility of hypoglycemia recognition with a newly trained group of dogs. The goal of the study is to show reproducibility of the dogs’ ability to recognise hypoglycemia from multiple samples in a laboratory setting. This is the first step to validate this mode of hypoglycemia therapy. Studies are also planned to determine what the dogs sense and to measure the dogs’ impact on patients as they are placed using Lilly’s proprietary measurement questionnaire.

 

Are you looking for a new job in the clinical industry?

 Click here to see our latest clinical jobs

Posted in Industry News, NewsTagged in , , , , , , , , , , , ,

Novartis Afinitor cancer treatment gets EU approval

As reported by Pharma times, Novartis’s Afinitor has now been approved in Europe as a treatment for advanced breast cancer.

The European Commission has approved Afinitor (everolimus) for use in combination with Pfizer’s Aromasin (exemestane) to treat certain postmenopausal women with advanced hormone-receptor positive, HER2-negative breast cancer

Herve Hoppenot, Novartis Oncology president, said the approval of Afinitor is “an important milestone marking the first major advance for women in the European Union with hormone receptor-positive advanced breast cancer since the introduction of aromatase inhibitors more than 15 years ago!”

This could mean that by boosting the effectiveness of endocrine therapy, Afinitor significantly extends the time women with hormone receptor-positive advanced breast cancer live without tumour progression.

Click here to see our latest clinical roles in the UK and Europe

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , ,

Free flu vaccinations for all children in the UK using AZ’s Fluenz

The BBC has reported that the UK government have announced that children between the ages of two to 17-year-olds in the UK are to be offered annual flu vaccinations free of charge.

This will be the first initiative of its kind in the world and the Joint Committee on Vaccination and Immunisation (JCVI) believes even with moderate vaccination uptake among children of around 30% there will be 11,000 fewer hospitalisations and 2,000 fewer deaths each year. The children will be immunised using a nasal spray rather than an injection, starting in 2014 at the earliest.

The news is particularly good for AstraZeneca, as the JCVI has advised that its live attenuated intranasal influenza vaccine Fluenz should be the vaccine of choice for extending the programme, “given the evidence of effectiveness, protection against drifted strains and safety, and in the absence of any equivalently effective alternative authorised vaccine”.

 

Are you looking for a new job in the clinical industry?

 Click here to see our latest clinical jobs

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , ,

Our Latest Pharmaceutical Jobs – 16.07.2012

Looking for a job in the Pharmaceutical Industry? Please click on the links below to find out about our latest pharmaceutical jobs new in this week:

Clinical:

GMP Auditor, Switzerland

Project Manager Study Start-up, Europe, Home based

CRA / Senior CRA, NW UK, home based

Clinical Research Manager, Cambridge / Middlesex

Interim Project Manager Study Start-up, Home based

Clinical Project Manager – Oxfordshire

Senior Associate, Clinical Study Management

Biometrics in the UK and Europe:

Senior Pharmacovigilance – Switzerland

Medic:

Interim Head of Medical Affairs

Medical Affairs Manager – Immunology

Senior Medical Advisor

Regulatory Affairs:

Hub Labelling Manager (EM)

 

Register your CV with CK Clinical

Not quite what you’re looking for? Click here to register your CV with CK Clinical today.

Once registered, one of our specialist Pharmaceutical Recruitment Consultants will be in contact to discuss your requirements and any relevant pharmaceutical jobs we are recruiting for at the moment. Good luck with your job hunt!

 

 

Posted in Industry News, NewsTagged in , , , , , , , , , , , , , , , , , , , , ,